About
Eikon Therapeutics is a biotechnology company founded in 2019 and headquartered in Hayward, California. It specializes in drug discovery and development by integrating Nobel Prize-winning super-resolution microscopy, advanced engineering, and high-performance computing to observe and measure protein dynamics in living cells. Eikon’s proprietary technologies enable the visualization of real-time biological processes, facilitating the development of breakthrough therapies for grievous illnesses such as cancer.
The company’s multidisciplinary team leverages automation and data science to accelerate the creation of innovative medicines, with operations spanning California, New Jersey, and New York.
